Public Employees Retirement Association of Colorado Has $4.12 Million Stock Position in Humana Inc. (NYSE:HUM)

Public Employees Retirement Association of Colorado reduced its holdings in Humana Inc. (NYSE:HUM) by 2.7% in the fourth quarter, HoldingsChannel reports. The firm owned 16,232 shares of the insurance provider’s stock after selling 454 shares during the period. Public Employees Retirement Association of Colorado’s holdings in Humana were worth $4,118,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in the business. FPC Investment Advisory Inc. acquired a new position in shares of Humana during the 4th quarter valued at $27,000. Centricity Wealth Management LLC bought a new stake in Humana in the fourth quarter valued at $30,000. LFA Lugano Financial Advisors SA increased its stake in Humana by 56.3% in the fourth quarter. LFA Lugano Financial Advisors SA now owns 125 shares of the insurance provider’s stock valued at $32,000 after purchasing an additional 45 shares in the last quarter. OFI Invest Asset Management acquired a new position in shares of Humana during the fourth quarter valued at about $33,000. Finally, Transce3nd LLC bought a new position in shares of Humana during the 4th quarter worth about $38,000. 92.38% of the stock is owned by institutional investors and hedge funds.

Humana Price Performance

HUM opened at $258.91 on Wednesday. Humana Inc. has a fifty-two week low of $213.31 and a fifty-two week high of $406.46. The firm has a 50-day moving average of $266.05 and a 200 day moving average of $270.76. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76. The firm has a market cap of $31.25 billion, a P/E ratio of 26.02, a PEG ratio of 2.05 and a beta of 0.62.

Humana (NYSE:HUM) last released its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, beating analysts’ consensus estimates of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. On average, research analysts expect that Humana Inc. will post 16.47 EPS for the current year.

Humana Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be paid a $0.885 dividend. The ex-dividend date is Friday, June 27th. This represents a $3.54 annualized dividend and a dividend yield of 1.37%. Humana’s payout ratio is presently 35.58%.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on HUM. Mizuho boosted their target price on Humana from $305.00 to $316.00 and gave the company an “outperform” rating in a research report on Wednesday, April 9th. Truist Financial boosted their price objective on Humana from $290.00 to $325.00 and gave the company a “hold” rating in a report on Friday, April 11th. StockNews.com upgraded Humana from a “hold” rating to a “buy” rating in a report on Monday, April 7th. JPMorgan Chase & Co. decreased their price target on shares of Humana from $257.00 to $256.00 and set a “neutral” rating for the company in a research note on Tuesday, February 18th. Finally, Robert W. Baird upped their price objective on shares of Humana from $270.00 to $300.00 and gave the stock a “neutral” rating in a report on Tuesday, April 15th. Seventeen equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat, Humana presently has an average rating of “Hold” and an average price target of $284.90.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.